Form 4: Zimmer Biomet Director Maria Teresa Hilado Reports Phantom Stock Unit Acquisition

Director Maria Teresa Hilado reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Summary

• Maria Teresa Hilado, a director of Zimmer Biomet Holdings, Inc., filed a Form 4 on July 2, 2024, reporting a transaction on June 30, 2024.
• The transaction involved the acquisition of 253.503 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The price of the phantom stock units was $108.48.
• Following the reported transaction, Hilado directly owns 8,486.617 shares of common stock and 253.503 phantom stock units.
• The phantom stock units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing indicating standard compensation practices. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Future Outlook

The phantom stock units will be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Industry Context

This filing is a routine disclosure related to director compensation and holdings, common in publicly traded companies like Zimmer Biomet.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it relates to director compensation.

Key Dates